News
BMS and Moffitt Cancer Center Enter Into a Collaboration Agreement |...
www.technologynetworks.com
Agreement as part of U.S. Immuno-Oncology Rare Population Malignancy program.
BMS, Moffitt In Immuno-Oncology Initiative - Contract Pharma
www.contractpharma.com
Will conduct early phase clinical studies in rare population malignancies
Bristol Myers Squibb : BMS and The Ohio State University...
www.marketscreener.com
Bristol-Myers Squibb Company and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J....
Bristol-Myers Squibb allies with Dana-Farber Cancer Institute
www.zenopa.com
Bristol-Myers Squibb and the Dana-Farber Cancer Institute have announced a new immuno-oncology research collaboration.
sortiert nach Relevanz / Datum